An Updated Role of Anastrozole in Male Factor Infertility for Avoidance of Need for Assisted Reproductive Technology ART A Short Communication
Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2023, Vol 7, Issue 4
Abstract
Male factor infertility causes infertility in about 50% couples. Aromatase hampering agents, like anastrozole restricts the transformation of testosterone (T) to estradiol (E2), minimize negative hampering on pituitary accessibility, and escalate endogenous Gn generation. Aromatase hampering agents have been offered historically to patients with a T: E2 ratio <10. Anastrozole, a more selective hampering agent in contrast to prior agents, has been illustrated to decrease serum E2 quantities and improvement of semen parameters in men with a low T: E2 ratio . Despite, escalated utilization of anastrozole for the treatment of infertile men with escalated peripheral estrogen, it is uncertain if a broader cohort may benefit also from therapy. For corroborating that Naelitz BD, et al. revealed in a multi institutional retrospective cohort study with regards to infertile men with the objective to evaluate the anticipative factors for World Health Organization -sperm concentration category (WHO-SCC)upgrade in case of male patients receiving anastrozole treatment. Their observations were that anastrozole Initiation was correlated with decreased serum estradiol (E2), escalated serum gonadotropin (Gn) quantities, and clinical improvement of semen paradigms in approximately 50% of infertile men. Baseline generation of sperms and greater T: LH ratios anticipated an upgrade of WHO-SCC. E2 quantities, E2: T ratio, and BMI revealed poor anticipative power in this cohort. Men with pretreatment azoospermia displayed poor response to anastrozole needing other treatment modalities. Non-azoospermic infertile men with a T-LH ratio ≥100 (in addition to a lesser degree those with a ratio <100) might gain advantage from treatment with anastrozole and get counseled regarding the anticipated probability of a clinically significant enhancement in semen paradigm. This might expand the availability of different therapies to couples who present with male factor infertility also aid in a trial of lesser invasive / costly fertility treatments.
Authors and Affiliations
Kaur KK* , Allahbadia GN and Singh M
Keywords
Related Articles
- EP ID EP758977
- DOI 10.23880/mjccs-16000343
- Views 1
- Downloads 0
The Human Chromosome 21 Gene TIAM-1 Over-Expressed in Down Syndrome Could be a Valuable Predictive Biomarker and a Potential Therapeutic Target for Treatment of Multiple Clinical Tumors and Cancers
Down syndrome, the triplication of human chromosome 21, is the most frequent genetic disorder associated to numerous diseases with hard impact on public health. Remarkably, the over-expression of most genes on this chrom...
Clinical Picture of COVID19 in Indian Children, Rarity of COVID Toes or Hands
The incidence of Covid 19 affecting children and young adults has been around 1 to 2% of total cases
Acral Peeling Skin Disease: About 2 Cases
Acral peeling skin syndrome is a rare, autosomal, recessive genodermatosis characterized by painless spontaneous exfoliation of the skin of the hands and feet at a subcorneal or intracorneal level. We are reporting 2 ca...
Asymptomatic High Grade Osteosarcoma of Proximal Tibia: A Case Report
Osteosarcomas are primary malignant tumors that are characterized by the production of osteoid or immature bone. Osteosarcoma is a deadly form of musculoskeletal cancer that most commonly causes patients to die from pul...
Hirschsprung Diseases should be Treated by Single or Two Stage Operations? A Case Report in a Resource-Low Setting in Cameroon
Background: Hirschsprung disease is a developmental disorder characterized by the absence of ganglia in the distal colon, resulting in a functional obstruction. Hirsch sprung disease is common in the paediatric age grou...